Skip to main content
NCBI home page
Journal of Clinical Pathology. Supplement (Royal College of Pathologists) logoLink to Journal of Clinical Pathology. Supplement (Royal College of Pathologists)
. 1975;9:46–49.

Immunological mechanisms in drug-induced blood dyscrasias

Urs Nydegger 1, Peter A Miescher 1
PMCID: PMC1347179  PMID: 783213

Full text

PDF
46

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blomgren S. E., Condemi J. J., Bignall M. C., Vaughan J. H. Antinuclear antibody induced by procainamide. A prospective study. N Engl J Med. 1969 Jul 10;281(2):64–66. doi: 10.1056/NEJM196907102810203. [DOI] [PubMed] [Google Scholar]
  2. Carstairs K. C., Breckenridge A., Dollery C. T., Worlledge S. M. Incidence of a positive direct coombs test in patients on alpha-methyldopa. Lancet. 1966 Jul 16;2(7455):133–135. doi: 10.1016/s0140-6736(66)92422-6. [DOI] [PubMed] [Google Scholar]
  3. Cochrane C. G., Koffler D. Immune complex disease in experimental animals and man. Adv Immunol. 1973;16(0):185–264. doi: 10.1016/s0065-2776(08)60298-9. [DOI] [PubMed] [Google Scholar]
  4. Eyster M. E., Jenkins D. E., Jr Gamma G erythrocyte autoantibodies: comparison of in vivo complement coating and in vitro "Rh" specificity. J Immunol. 1970 Jul;105(1):221–226. [PubMed] [Google Scholar]
  5. Gillespie E. Colchicine binding in tissue slices. Decrease by calcium and biphasic effect of adenosine-3', 5'-monophosphate. J Cell Biol. 1971 Aug;50(2):544–549. doi: 10.1083/jcb.50.2.544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gralnick H. R., McGinniss M., Elton W., McCurdy P. Hemolytic anemia associated with cephalothin. JAMA. 1971 Aug 30;217(9):1193–1197. [PubMed] [Google Scholar]
  7. Gralnick H. R., McGinniss M., Halterman R. Thrombocytopenia with sodium cephalothin therapy. Ann Intern Med. 1972 Sep;77(3):401–404. doi: 10.7326/0003-4819-77-3-401. [DOI] [PubMed] [Google Scholar]
  8. HARRIS J. W. Studies on the mechanism of a drug-induced hemolytic anemia. J Lab Clin Med. 1956 May;47(5):760–775. [PubMed] [Google Scholar]
  9. HOLLAND P., MAUER A. M. DIPHENYLHYDANOIN-INDUCED HYPERSENSITIVITY REACTION. J Pediatr. 1965 Feb;66:322–332. doi: 10.1016/s0022-3476(65)80189-5. [DOI] [PubMed] [Google Scholar]
  10. HUGULEY C. M., Jr AGRANULOCYTOSIS INDUCED BY DIPYRONE, A HAZARDOUS ANTIPYRETIC AND ANALGESIC. JAMA. 1964 Sep 21;189:938–941. doi: 10.1001/jama.1964.03070120060014. [DOI] [PubMed] [Google Scholar]
  11. Halpern B., Ky N. T., Amache N., Lagrue G., Hazard J. Diagnostic de l'allergie médicamenteuse "in vitro" par l'utilisation du test de ransformation lymphoblastique (T.T.L.) Presse Med. 1967 Feb 25;75(10):461–465. [PubMed] [Google Scholar]
  12. Karpatkin S. Drug-induced thrombocytopenia. Am J Med Sci. 1971 Aug;262(2):68–78. doi: 10.1097/00000441-197108000-00001. [DOI] [PubMed] [Google Scholar]
  13. Levine B. B., Fellner M. J., Levytska V., Franklin E. C., Alisberg N. Benzylpenicilloyl-specific serum antibodies to penicillin in man. II. Sensitivity of the hemagglutination assay method, molecular classes of the antibodies detected, and antibody titers of randomly selected patients. J Immunol. 1966 Apr;96(4):719–726. [PubMed] [Google Scholar]
  14. MIESCHER P. Leucopénies et agranulocytoses d'origine immunologique. Sang. 1955;26(1):71–76. [PubMed] [Google Scholar]
  15. MOESCHLIN S., MORENO R. Pyramidon-Agranulocytose mit Agglutininen für arteigene und artfremde Leukocyten. Klin Wochenschr. 1954 Sep 1;32(33-34):799–802. doi: 10.1007/BF01477610. [DOI] [PubMed] [Google Scholar]
  16. MOESCHLIN S., WAGNER K. [Agranulocytosis due to the occurrence of leukocyte-agglutinins; pyramidon and cold agglutinins]. Acta Haematol. 1952 Jul-Aug;8(1-2):29–41. doi: 10.1159/000204146. [DOI] [PubMed] [Google Scholar]
  17. Miescher P. A. Drug-induced thrombocytopenia. Semin Hematol. 1973 Oct;10(4):311–325. [PubMed] [Google Scholar]
  18. PERRY H. M., Jr, SCHROEDER H. A. Syndrome simulating collagen disease caused by hydralazine (Apresoline). J Am Med Assoc. 1954 Feb 20;154(8):670–673. doi: 10.1001/jama.1954.02940420032009. [DOI] [PubMed] [Google Scholar]
  19. Pfueller S. L., Lüscher E. F. The effects of aggregated immunoglobulins on human blood platelets in relation to their complement-fixing abilities. I. Studies of immunoglobulins of different types. J Immunol. 1972 Sep;109(3):517–525. [PubMed] [Google Scholar]
  20. SHULMAN N. R. Immunoreactions involving platelets. I. A steric and kinetic model for formation of a complex from a human antibody, quinidine as a haptene, and platelets; and for fixation of complement by the complex. J Exp Med. 1958 May 1;107(5):665–690. doi: 10.1084/jem.107.5.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. TULLIS J. L. Prevalence, nature and identification of leukocyte antibodies. N Engl J Med. 1958 Mar 20;258(12):569–578. doi: 10.1056/NEJM195803202581201. [DOI] [PubMed] [Google Scholar]
  22. WEISSMANN G., XEFTERIS E. D. Phenylbutazone leukopenia. AMA Arch Intern Med. 1959 Jun;103(6):957–961. doi: 10.1001/archinte.1959.00270060109014. [DOI] [PubMed] [Google Scholar]
  23. Worlledge S. M. Immune drug-induced hemolytic anemias. Semin Hematol. 1973 Oct;10(4):327–344. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology. Supplement (Royal College of Pathologists). are provided here courtesy of BMJ Publishing Group

RESOURCES